泰格医药 (300347.sz)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(泰格医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 1,660,204,321.447,384,039,460.885,650,477,938.013,710,850,371.591,804,571,375.287,085,471,468.875,406,018,843.593,594,209,238.111,817,858,958.69
 营业利润(元) 362,196,228.412,486,940,557.422,311,724,272.621,598,597,788.22630,897,782.902,582,398,509.042,001,007,232.461,480,920,291.19654,381,329.25
 利润总额(元) 362,364,203.952,488,533,058.162,314,469,415.051,599,145,093.00631,062,128.032,585,377,423.932,006,001,109.661,479,865,240.74656,002,308.83
 净利润(元) 312,570,373.392,149,926,843.572,027,846,971.741,408,089,992.74568,325,660.272,271,725,425.731,772,234,409.941,317,626,006.74573,970,498.59
 归属于母公司股东的净利润(元) 235,072,002.702,024,849,989.111,879,604,430.161,388,337,006.20568,455,092.872,006,552,035.301,604,658,753.471,192,004,036.35518,416,798.73
盈利能力:
 销售毛利率(%) 37.8338.5840.3439.9139.6539.6440.1139.7038.83
 销售净利率(%) 18.8329.1235.8937.9531.4932.0632.7836.6631.57
 净资产收益率(%) 1.149.979.347.082.95----
 总资产报酬率ROA(%) 1.178.337.725.462.32----
 投入资本回报率ROIC(%) 0.978.828.136.062.559.837.936.022.68
营运能力:
 存货周转率(次) 44.11198.92108.16102.5270.79----
 应收账款周转率(次) 1.456.455.483.531.91----
 总资产周转率(次) 0.060.260.200.130.07----
偿债能力:
 资产负债率(%) 18.4117.6118.3619.2417.2317.3618.2216.3614.63
 股东权益比率(%) 70.2870.8470.0369.3971.5171.3570.7172.5874.20
 已获利息倍数(倍) -15.53-21.97-20.88-17.15-38.54-15.35-15.87-16.81-20.63
 流动比率 2.612.742.682.582.952.982.723.123.52
 速动比率 2.542.672.622.522.882.902.653.083.48
发展能力:
 营业收入增长率(%) -8.004.214.523.25-0.7335.9159.2374.78101.55
 营业利润增长率(%) -42.59-3.7015.537.95-3.59-30.15-14.52-12.73-13.48
 税后利润增长率(%) -58.650.9117.1316.479.65-30.19-9.90-5.0213.82
 净资产增长率(%) 4.907.379.7410.359.458.0511.689.6612.07
 总资产增长率(%) 6.748.1410.8015.4213.5815.6123.6221.1222.30

前瞻产业研究院